Phosphorylcholine-conjugated gold-molecular clusters improve signal for Lymph Node NIR-II fluorescence imaging in preclinical cancer models.
Ani BaghdasaryanFeifei WangFuqiang RenZhuoran MaJiachen LiXueting ZhouLilit GrigoryanChun XuHongjie DaiPublished in: Nature communications (2022)
Sentinel lymph node imaging and biopsy is important to clinical assessment of cancer metastasis, and novel non-radioactive lymphographic tracers have been actively pursued over the years. Here, we develop gold molecular clusters (Au 25 ) functionalized by phosphorylcholine (PC) ligands for NIR-II (1000-3000 nm) fluorescence imaging of draining lymph nodes in 4T1 murine breast cancer and CT26 colon cancer tumor mouse models. The Au-phosphorylcholine (Au-PC) probes exhibit 'super-stealth' behavior with little interactions with serum proteins, cells and tissues in vivo, which differs from the indocyanine green (ICG) dye. Subcutaneous injection of Au-PC allows lymph node mapping by NIR-II fluorescence imaging at an optimal time of ~ 0.5 - 1 hour postinjection followed by rapid renal clearance. Preclinical NIR-II fluorescence LN imaging with Au-PC affords high signal to background ratios and high safety and biocompatibility, promising for future clinical translation.
Keyphrases
- fluorescence imaging
- lymph node
- photodynamic therapy
- sentinel lymph node
- sensitive detection
- neoadjuvant chemotherapy
- reduced graphene oxide
- papillary thyroid
- high resolution
- squamous cell
- mouse model
- blood pressure
- induced apoptosis
- ultrasound guided
- small molecule
- gold nanoparticles
- young adults
- magnetic resonance imaging
- childhood cancer
- cell death
- cell proliferation
- locally advanced
- silver nanoparticles
- endoplasmic reticulum stress
- bone marrow